Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based StudyChristelle Nilles, Aurélia Poujois, Corinne Collet et al.|Movement Disorders|2022Cited by 26
Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosisNouzha Djebrani‐Oussedik, Aurélia Poujois, Clément Desjardins et al.|JHEP Reports|2025Cited by 11
Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HClIsabelle Mohr, Karl Heinz Weiss, Hélène Bourhis et al.|Journal of Gastroenterology and Hepatology|2022Cited by 10
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trialChloé Laurencin, Stéphane Thobois, Aurélia Poujois et al.|European Journal of Neurology|2024Cited by 1
Efficacité et tolérance de deux sels de trientine dans le traitement de la maladie de WilsonFrance Woimant, Aurélia Poujois, Mickaël Alexandre Obadia et al.|Revue Neurologique|2021Cited by 0